Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.82 USD | -1.30% | +5.98% | +52.88% |
04-02 | ADMA Biologics, Inc. Announces Promotion of Kaitlin Kestenberg as Chief Operating Officer | CI |
03-26 | HC Wainwright Adjusts ADMA Biologics Price Target to $7.50 From $6, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.88% | 1.6B | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.40% | 31.87B | |
+53.42% | 24.52B | |
-14.35% | 15.68B | |
-6.52% | 12.34B | |
-39.65% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- ADMA Stock
- News ADMA Biologics, Inc.
- HC Wainwright Adjusts ADMA Biologics Price Target to $7.50 From $6, Maintains Buy Rating